Here's the only book to define the new core competencies revolutionizing neurology certification and recertification. Written and sponsored by the American Board of Psychiatry and Neurology (ABPN)-the official accrediting organization in this specialty-it spells out all of the knowledge needed to achieve and maintain professional certification.
The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms.
Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.
The original task force report, completed in the summer of 1994, reflected the current state of addiction treatment and provided recommendations for improving these services in the future. That monograph is reproduced in this book, which accomplishes the following: * Define psychiatrists' current roles and practices in the treatment of substance-dependent patients in relationship to that of other practitioners, with particular attention to issues such as dual diagnosis, methadone treatment, and detoxification* Develop suggestions for appropriate funding mechanisms for the payment of addicted patients' treatment in the context of managed care and indemnity benefit programs* Examine issues related to the funding of public sector programs, including funding of Department of Veterans Affairs programs, block grant funding of state and city programs, as well as funding of voluntary treatment programs within and outside the criminal justice system. This book is divided into four sections. Chapter 1 reviews the history of American psychiatry's interest in addiction disorders and the development of the current network of addiction treatment services. Chapter 2 is a snapshot of the current addiction treatment system, with a description of the services provided in general medical settings, psychiatric hospitals, freestanding residential facilities, and private practice and other outpatient settings. Chapter 3 explores the economics of the treatment system: the costs of addictive diseases to American society and the costs and sources of support for their treatment. Chapter 4 examines the range of system modifications and resource allocations needed to bring high quality, cost-effective treatment to addicted patients and their families. These needs range from improving data collection and treatment research to increasing community involvement and the application of current research findings.
The past decade has witnessed remarkable growth in the field of quality measurement in health care. Today's patients want to know that the care they receive is safe, effective, and accessible. This compelling monograph combines -- for the first time -- the reports from two American Psychiatric Association task forces on quality in psychiatric care (March 1999, which focused on adults, and October 2001, which focused on children and adolescents), offering a clinical framework for quality measurement that provides sample indicators of quality for health plans, facilities, and systems of care. Using similar formats and definitions, each task force considered a matrix of priority areas of care, including specific patient populations (e.g., elderly, seriously and persistently mentally ill, developmentally disabled people) and diagnostic categories (e.g., depressive disorder, schizophrenia, substance use disorders). Each then examined important aspects of patient care and constructed a quality framework that included dimensions of access, quality (appropriateness of care), perception of care (satisfaction), outcome, and -- for the children's report -- prevention. Each task force also considered relevant methodological issues: cultural, linguistic, and ethnic differences; data collection and tracking; confidentiality of data; risk adjustment; use of rating scales and standardized instruments; and designation of standards. Sample recommended goals include For adults: patients with serious and persistent mental illness should have access to newer generations of antipsychotic medications as these become available; patients should achieve a significant reduction in symptom. For children and adolescents: the mental health status of children and adolescents should be assessed annually; children with severe or persistent mental illness whose care involves multiple child-serving systems, caregivers, and service providers should have their care coordinated Sample indicators include For adults: utilization of new antipsychotics for patients with the diagnosis of schizophrenia; reduction in frequency of panic attacks in patients with the diagnosis of panic disorder For children and adolescents: high levels of satisfaction of adolescents using mental health services or substance abuse services; reduction in a family's stress level and impact of illness As the initial step in what must be an evolving effort by clinicians to define, measure, report, and improve the care that patients and their families receive, this monograph is essential reading for those who provide and receive care, accredit and regulate care, and purchase and administer clinical services. Purchasers of mental health care want clear, reliable, meaningful, and comparable information on what care is provided and with what results. APA convened these two task forces to lend its professional expertise to that issue, to advise on how to develop clinically based, patient focused quality indicators that use existing and ongoing research and clinical consensus in selecting potential indicators.
The fascinating Psychopathology in the Genome and Neuroscience Era brings together selected topics in psychiatric genetics, epidemiology and prevention, and neuroscience and education. This key reference integrates this information across the fields of genetics, epidemiology, and neuroscience to arrive at an understanding of where recent advances in genetics and neuroscience -- advances that promise to enhance our understanding of human behavior and psychopathology -- are likely to influence psychopathology research and education in the near future. How will the field of psychopathology incorporate the coming avalanche of information generated by these recent advances? The answer will influence not only how mental health professionals diagnose and treat patients but also how the next generation of professionals is trained. Chapters in this exciting compilation are based on individual talks by 20 international experts at the conceptual forefront of their respective fields given at the March 2003 American Psychopathological Association annual meeting. Organized into four main sections -- the future of psychiatric genetics, diagnosis and prevention of psychiatric disorders, neurobiology and psychiatric disorders, and the future of psychiatric education -- Psychopathology in the Genome and Neuroscience Era focuses on a broad range of topics: The importance of a conceptual shift from identifying major genes for mental disorders to gaining an understanding of the role of which genes in which contexts, both biological and environmental, confer susceptibility to or protection from mental disorders or components thereof Historical perspective of gene susceptibility to mental disorders, with the same possibilities for use and misuse of genotype data as now exist for significantly heritable traits such as intelligence, and for borderline traits such as criminal behavior and alcoholism Reconceptualization of medicine and medical diagnoses to include molecular genetic components, including the importance of cell loss and neurogenesis in mood disorders Major phenotypic problems inherent in all attempts to measure psychopathology, starting with how to achieve reliability, and how to advance from reliability to validity in future revisions of DSM and ICD classifications Brain structural abnormalities in mood disorders; physiological cell death and whether or not this natural phenomenon can be converted into a pathological process, including the importance of cell loss and neurogenesis in mood disorders The influence of scientific advances, workforce issues, and educational trends on psychiatric training Psychopathology in the Genome and Neuroscience Era is a must-read reference work for anyone -- practitioners, residents, and students alike -- interested in the future of psychiatric genetics, epidemiology, and education.
Here's the only book to define the new core competencies revolutionizing neurology certification and recertification. Written and sponsored by the American Board of Psychiatry and Neurology (ABPN)-the official accrediting organization in this specialty-it spells out all of the knowledge needed to achieve and maintain professional certification.
Authored by the two primary organizations in the field, Legal Medicine: Health Care Law and Medical Ethics, 8th Edition, remains the premier treatise in this increasingly important area of medical practice. In the midst of a progressively litigious culture, this essential reference provides up-to-date information on topics surrounding professional medical liability, the business aspects of medical practice, and medicolegal and ethical issues, offering comprehensive discussions on a myriad of topics that health care professionals face every day. - Addresses the legal aspects of almost every medical topic that impacts health care professionals, using actual case studies to illustrate nuances in the law. - Offers the expert guidance of top professionals across medical and legal fields in an easy-to-read format. - Includes new chapters on Legal Medicine History; Healthcare Technology; Patients with Infectious Diseases (HIV Infection and COVID-19); General Pain Management; Opioids and Illicit Drugs: Misuse, Abuse and Addiction; Cannabis (Marijuana); Drug (Treatment) Courts; and Public Health Law and Policy. - Provides authoritative information on current issues such as the high costs of medical liability insurance for practitioners and organizations; changes in health care and the law, including HIPAA and patient privacy; the overturning of Roe v. Wade; the opioid epidemic, and more. - Features Key Points boxes to open every chapter, Pearls boxes to call out important details, additional diagrams and tables throughout, a glossary of medical terms, and updated references and suggested readings. - Serves as the syllabus for the Board Review Course of the American Board of Legal Medicine (ABLM).
Two decades of advances related to electroconvulsive therapy (ECT) prompted the American Psychiatric Association Task Force on Electroconvulsive Therapy to update the recommendations for its use. This volume is the result of that work. This third edition of The Practice of Electroconvulsive Therapy—the first since 2001—captures the body of knowledge on the safety, efficacy, and practice of ECT accumulated over the past 20 years, including more than 1,100 new literature citations. New features of this book include • Chapters on detecting and managing adverse effects, including cognitive side effects, and assessing treatment outcomes to support measurement-based care• A discussion of approaches to optimize response and reduce relapse, including use of maintenance ECT, and guidance for management of patients not responding to an acute ECT course• An overview of the 2018 United States Food and Drug Administration's reclassification of ECT devices and its implications for clinical practice• A chapter on other neuromodulation techniques, including transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation, and emerging neuromodulation approaches Like its predecessors, this edition provides comprehensive information on staffing, assessment, and preparation for ECT; informed consent; anesthestic management; stimulus electrode placement; electrical stimulus parameters and dosing; seizure monitoring; and much more. The use of ECT in special circumstances—including in patients with catatonia, in children and adolescents, and during pregnancy—is also discussed. With detailed information on concurrent medications and medical comorbidities that may require modifications to treatment, as well as indications for the use of ECT, this book is an indispensable guide to state-of-the-art ECT practice.
ASAM Patient Placement Criteria: Supplement on Pharmacotherapies for Alcohol Use Disorders provides a framework for placing patients with alcohol use disorders, using the ASAM criteria. Chapters address pharmacotherapies and behavioral therapies for alcohol withdrawal and for prevention and management of relapse. Case examples bolster understanding of the recommendations made.
The "Green Book" is the definitive guide to graduate medical education (residency) programs for thousands of medical students, administrators, researchers and librarians. It is the only single published source of programs accredited by the Accreditation Council for Graduate Medical Education (ACGME) and is used by students in selecting programs, and by licensing boards for verifying the authenticity of programs presented by physicians. All of the essential information for graduate medical education is included: -- Complete, accurate listings for more than 8,000 ACGME-accredited programs and 1,600 GME teaching institutions -- Accreditation Council on Graduate Medical Education Institutional and Program Requirements for 113 specialties/subspecialties -- Medical specialty board certification requirements -- Name, address, phone and fax numbers, and e-mail addresses of all the directors of GME programs -- GME glossary and list of US medical schools -- More than 6,500 revisions to the previous edition
The seventh edition of the Directory of Psychiatry Residency Training Programs is an essential reference tool for those entering the field of psychiatry. This easy-to-use directory provides a systematic and complete description of accredited residency programs in general and child and adolescent psychiatry that will help prospective residents to select the programs that most interest them. This reference is the product of a joint effort between the American Psychiatric Association (APA), the American Association of Directors of Psychiatric Residency Training (AADPRT), the American Medical Student Association (AMSA), and the Student National Medical Association (SNMA). Equipped with the important information in this directory, prospective residents can make informed choices about their residency training and ensure a brighter, more rewarding career.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.